| P2093 | author name string | A K Dash | |
| | A A Nagvekar | |
| | W J Trickler | |
| P2860 | cites work | Albumin-bound paclitaxel: a next-generation taxane | Q29027108 |
| | Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation | Q33182379 |
| | A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery. | Q33214432 |
| | Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems | Q33223515 |
| | Mucoadhesive nanoparticulate systems for peptide drug delivery | Q34184353 |
| | Recent advances on chitosan-based micro- and nanoparticles in drug delivery | Q34359954 |
| | Nanoparticle technology for drug delivery across the blood-brain barrier | Q34540557 |
| | Paclitaxel and its formulations | Q34552648 |
| | Physical chemical considerations of lipid-based oral drug delivery--solid lipid nanoparticles | Q35751688 |
| | Targeting intracellular targets | Q36320723 |
| | Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems | Q36488939 |
| | Update on nanoparticle albumin-bound paclitaxel. | Q36651441 |
| | Cubosomes: an overview | Q36724516 |
| | Nanoparticles in drug delivery. | Q38593607 |
| | Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study | Q40214199 |
| | A mucoadhesive in situ gel delivery system for paclitaxel | Q40263358 |
| | Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree | Q40315864 |
| | Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel | Q40320517 |
| | Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity | Q40397218 |
| | Taxol: a promising new drug of the '90s. | Q40619659 |
| | In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer | Q40759040 |
| | RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. | Q42799200 |
| | Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. | Q43687728 |
| | X-ray powder diffractometric method for quantitation of crystalline drug in microparticulate systems. I. Microspheres | Q43956125 |
| | Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel | Q43990070 |
| | Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: a phase II trial | Q44230179 |
| | A novel in situ gel for sustained drug delivery and targeting | Q44869101 |
| | Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate | Q46451833 |
| | A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin. | Q46983335 |
| | In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe | Q48009940 |
| | The effect of particle structure of chitosan-coated liposomes and type of chitosan on oral delivery of calcitonin. | Q51186895 |
| | Preparation and characterization of mucoadhesive polymer-coated nanoparticles. | Q51240262 |
| | Nanoparticles based on N-trimethylchitosan: Evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models | Q57360670 |
| | A new parenteral vehicle for the administration of some poorly water soluble anti-cancer drugs | Q68966372 |
| | Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes | Q71499864 |
| | Phase behavior of aqueous systems of monoglycerides | Q72598919 |
| | Hypersensitivity reactions from taxol and etoposide | Q72658938 |
| | Phase II study of Taxol in patients with advanced gastric carcinoma | Q74835089 |
| | Glyceryl monooleate cubic phase gel as chemical stability enhancer of cefazolin and cefuroxime | Q77622634 |
| | Abraxane induced life-threatening toxicities with metastatic breast cancer and hepatic insufficiency | Q82678758 |
| | Thiomers: preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system | Q83087906 |
| | Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel | Q83945388 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| | paclitaxel | Q423762 |
| P304 | page(s) | 486-493 | |
| P577 | publication date | 2008-03-18 | |
| P1433 | published in | AAPS PharmSciTech | Q15750612 |
| P1476 | title | A novel nanoparticle formulation for sustained paclitaxel delivery | |
| P478 | volume | 9 | |